Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

ABSTRACT:

SUBMITTER: Lim JQ 

PROVIDER: S-EPMC7685978 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature